ACBD3

Golgi resident protein GCP60 · Q9H3P7 · ACBD3 on Sugi Atlas →

0 patent compounds predicted against ACBD3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ACBD3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Ambroxol as a Treatment for Parkinson's Disease Dementia PHASE2UNKNOWN
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease nanUNKNOWN
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
Familial Partial Lipodystrophy Study nanCOMPLETED
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Chronic Obstructive Pulmonary Disease Gene Localization nanCOMPLETED
Study of Constitutional Platelet Disease nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a ACBD3 binder may also engage these)

ProteinNameSimilarity
Q8BMP6 1.000 Q8BMP6 →
Q7TNY6 1.000 Q7TNY6 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.989 landscape →
SMARCC1 SWI/SNF complex subunit SMARCC1 0.987 landscape →
P97496 0.986 P97496 →
Q09YG9 0.986 Q09YG9 →
Q09YJ3 0.986 Q09YJ3 →
Q8VDP4 0.985 Q8VDP4 →
Q9CYA6 0.985 Q9CYA6 →
Q02225 0.985 Q02225 →
P35611 0.985 P35611 →
Q2IBF8 0.984 Q2IBF8 →
Q7T0S7 0.984 Q7T0S7 →
Q6PDG5 0.984 Q6PDG5 →
Q80U87 0.984 Q80U87 →
Q9ULJ8 0.984 Q9ULJ8 →
Q9D3S3 0.984 Q9D3S3 →
Q8VIJ5 0.984 Q8VIJ5 →
Q08E13 0.984 Q08E13 →
A0M8T5 0.984 A0M8T5 →
Q05764 0.984 Q05764 →
Q2IBE6 0.984 Q2IBE6 →
ASH2L Set1/Ash2 histone methyltransferase complex subunit ASH2 0.984 landscape →
Q8TC92 0.984 Q8TC92 →
A1X157 0.983 A1X157 →
P39880 0.983 P39880 →
Q2IBA2 0.983 Q2IBA2 →
Q96C34 0.983 Q96C34 →
Q69ZZ6 0.983 Q69ZZ6 →
Q9JHD2 0.983 Q9JHD2 →